MedTrace Logo

Maitake for Integrative Cancer Care

NCT06323473 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-01-23

No results posted yet for this study

Summary

Maitake is an edible mushroom that is used for both its nutritional and medicinal properties. Human and animal studies have shown Maitake may help improve immune function; however, its effectiveness in people with cancer is not clear. The investigators aim to measure if Maitake has any immunomodulatory effects when given alongside conventional systemic cancer therapy.

Conditions

Interventions

DIETARY_SUPPLEMENT

Black Maitake Prothera

Mushroom extract; liquid

Sponsors & Collaborators

  • The Canadian College of Naturopathic Medicine

    lead OTHER

Principal Investigators

  • Adrienne Junek, MD · Centre for Health Innovation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-15
Primary Completion
2026-05-15
Completion
2026-05-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06323473 on ClinicalTrials.gov